New insider activity at Viatris ( (VTRS) ) has taken place on March 24, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Viatris has reported an insider stock transaction involving Paul Campbell, the company’s Chief Accounting Officer and Corporate Controller. Campbell sold 21,350 shares of Viatris stock, with the total value of the transaction amounting to $283,528. This sale provides a glimpse into recent insider activity at the company and may draw attention from investors monitoring executive trading patterns.
Recent Updates on VTRS stock
Viatris shares reacted to a mix of late-stage pipeline and earnings news, as the company reported solid Q4 and 2025 results while outlining only low single-digit growth for 2026 and margin pressure from losses of exclusivity and mix shifts. Analysts appear to be revisiting assumptions largely because management framed 2025–2028 as a back‑loaded transition, with cost savings, regulatory milestones and selective deals driving more meaningful upside only later in the decade.
Additional focus fell on Viatris’ strong cash generation, its plan for $650 million in gross cost savings, and the completed Phase 3 Nyxol night‑vision trial, which reduces development risk but lacks data so far. These factors support a more cash‑rich, pipeline‑enhanced story, yet near‑term earnings are clouded by restructuring charges, regional pricing headwinds and execution risks such as restarting the India plant, tempering expectations for immediate valuation re‑rating.
Spark’s Take on VTRS Stock
According to Spark, TipRanks’ AI Analyst, VTRS is a Neutral.
The score is held back primarily by weak profitability (deep 2025 losses and negative P/E) despite solid and stable cash flow. Technicals are supportive due to a strong uptrend, but momentum is overbought, limiting the technical score. Guidance and corporate actions (cost-savings program and Biocon stake sale) are constructive, though near-term margin pressure, manufacturing disruption risk, and sizable one-time restructuring costs temper the outlook.
To see Spark’s full report on VTRS stock, click here.
More about Viatris
YTD Price Performance: 7.70%
Average Trading Volume: 10,416,822
Technical Sentiment Signal: Buy
Current Market Cap: $15.3B